Cargando…
The role of ICAM-2 in neuroblastoma
Autores principales: | Yoon, Karina J., Miller, Aubrey L., Kreitzburg, Kelly M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675787/ https://www.ncbi.nlm.nih.gov/pubmed/26697524 |
Ejemplares similares
-
N-glycosylation of ICAM-2 is required for ICAM-2-mediated complete suppression of metastatic potential of SK-N-AS neuroblastoma cells
por: Feduska, Joseph M, et al.
Publicado: (2013) -
Sphingolipid metabolism and drug resistance in ovarian cancer
por: Kreitzburg, Kelly M., et al.
Publicado: (2018) -
ICAM-2 Expression Mediates a Membrane-Actin Link, Confers a Nonmetastatic Phenotype and Reflects Favorable Tumor Stage or Histology in Neuroblastoma
por: Yoon, Karina Jin, et al.
Publicado: (2008) -
See you at ICAM in Vancouver, April 2024!
por: D’Eon, Marcel F
Publicado: (2023) -
ICAM-1 and ICAM-2 Are Differentially Expressed and Up-Regulated on Inflamed Pulmonary Epithelium, but Neither ICAM-2 nor LFA-1: ICAM-1 Are Required for Neutrophil Migration Into the Airways In Vivo
por: Chong, Deborah L. W., et al.
Publicado: (2021)